You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 10, May 22, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Congestive Heart Failure/ Cardiomyopathy
 •Pathology & Laboratory Medicine
 •Alert me on articles by topic

The Value of BNP Testing

Arch Intern Med. 2006;166:1063-1064.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

B-type natriuretic peptide (BNP) is synthesized in ventricular myocardium and released into the circulation in response to increased wall stress.1-2 Levels of BNP can be measured rapidly using commercially available assays and have been evaluated for clinical value in a variety of settings. Recent research suggests that BNP levels can readily identify patients with heart failure and may be useful in the evaluation of patients with acute dyspnea, in screening for patients with left ventricular dysfunction, or in guiding management of patients with known heart failure. It is uncertain, however, whether measuring BNP affects clinical outcomes or whether the expense of the test is justified. In this editorial, we will briefly review principles of economic evaluation as applied to diagnostic tests, the evidence about BNP testing, and consider the cost-effectiveness of BNP testing in the assessment of patients with acute dyspnea.

VALUE OF INFORMATION

A laboratory test, such as BNP measurement, provides information . . . [Full Text of this Article]


BNP TESTING

THE BASEL STUDY

CONCLUSIONS

AUTHOR INFORMATION
Mark Hlatky, MD; Paul Heidenreich, MD, MS


RELATED ARTICLES

Accuracy of B-Type Natriuretic Peptide Tests to Exclude Congestive Heart Failure: Systematic Review of Test Accuracy Studies
Markus Battaglia, Daniel Pewsner, Peter Jüni, Matthias Egger, Heiner C. Bucher, and Lucas M. Bachmann
Arch Intern Med. 2006;166(10):1073-1080.
ABSTRACT | FULL TEXT  

Cost-effectiveness of B-Type Natriuretic Peptide Testing in Patients With Acute Dyspnea
Christian Mueller, Kirsten Laule-Kilian, Christian Schindler, Theresia Klima, Barbara Frana, Daniel Rodriguez, André Scholer, Michael Christ, and André P. Perruchoud
Arch Intern Med. 2006;166(10):1081-1087.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

BNP Testing: A Mixed Blessing
JWatch Emergency Med. 2006;2006:4-4.
FULL TEXT  

BNP Testing for Acute Dyspnea: Is It Cost-Effective?
Journal Watch Cardiology 2006;2006:6-6.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.